Physician profile
Eric Ginsberg
NPI 1194959098
$2,566.31
in general payments reported to CMS, 2019-2025
14 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $182 · 2021: $78.06 · 2022: $400 · 2023: $516 · 2024: $840 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $810.17 | 2021-2025 | Corevalve Evolut R, Endurant Iis, Symplicity G3 |
| Abbott Laboratories | $599.27 | 2020-2025 | Xience Skypoint, Nc Trek Neo, Viewmate |
| Boston Scientific Corporation | $318.22 | 2019-2025 | Watchman Access System, Cds - Mct/Cem Monitoring |
| Surmodics, INC. | $152.28 | 2024 | Pounce Thrombectomy System, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $145.24 | 2020 | |
| Shockwave Medical, INC | $143.12 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Organogenesis INC. | $120.73 | 2024 | Affinity |
| Medtronic Vascular, INC. | $95.60 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $50.47 | 2019-2024 | Xarelto |
| Solventum Corporation | $43.49 | 2024 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Astrazeneca Pharmaceuticals LP | $30.02 | 2019-2022 | |
| Novo Nordisk INC | $24.58 | 2024 | Wegovy |
| Acera Surgical, INC. | $18.95 | 2024 | Restrata Wound Matrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ginsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.